Rosa Petit

Medical Physicist | Physicist

Hi and Welcome to my Website!

Hey! I’m Rosa Angelica Petit Sevilla, born in Venezuela on May 15, 1993. I am dedicated, professional, and committed to delivering high-quality work. My personal qualities allow me to integrate seamlessly into any team. I consider myself positive and adaptable to all work environments.

I am passionate about science, which is evident in my professional and educational experiences. This passion led me to discover my love for writing, enabling me to express ideas and information clearly, ensuring accessibility to knowledge for everyone. Through these dual vocations, I have honed my organizational, classification, and communication skills. Follow me on Linkedin for more information.

Projects

SC20.03 Building Bridges for Professional Development through the Master of Advanced Studies in Medical Physics Alumni Association

The Master of Advanced Studies in Medical Physics Alumni Association (MMPAA) bridges graduates of the Medical Physics Program (MMP) at the Abdus Salam International Centre for Theoretical Physics (ICTP) in Trieste, Italy, and their professional paths. Aimed at fostering a global network of graduates of developing countries, MMPAA facilitates connections and knowledge exchange among its diverse international alumni base.

Statistical Process Control in Tomotherapy pre-treatment QA: Fixing tolerance and action limits for the verification metrics

Thesis supervisor Dr. Eleonora Vanzi explores the challenges in IMRT using helical Tomotherapy, highlighting the need for rigorous treatment plan verification due to dosimetric variability. Key methods include single-point absolute measurements and gamma index analysis using the Tomotherapy planning system’s DQA software, ensuring precise dose delivery and patient safety.

MP-EP03 #105 Statistical Control Process in Tomotherapy pre-treatment QA, Rosa Petit

Patient-specific QA using SPC and gamma analysis in helical TomotherapyTM with ArcCheckTM established tolerance and action limits across anatomical sites (abdomen, head & neck, breast + SVC, prostate). Results showed varied control limits, indicating stable processes in head & neck and prostate treatments compared to challenges in breast + SVC and abdomen due to dose distribution complexities.